Comparative proteomic analysis of rat aorta in a subtotal nephrectomy model

Area of Science:

• Cardiovascular research
• Nephrology
• Proteomics

Background:

• Accelerated atherosclerosis and arteriosclerosis are primary causes of cardiovascular disease in chronic kidney disease (CKD) patients.
• The molecular mechanisms underlying aortic stiffness in CKD remain poorly understood.

Purpose of the Study:

• To investigate the molecular pathogenesis of aortic stiffness in a rat model of CKD.
• To identify potential protein biomarkers and therapeutic targets for aortic stiffness in CKD.

Main Methods:

• Subtotal nephrectomy (SNX) model in rats to induce CKD and aortic stiffness.
• Two-dimensional gel electrophoresis (2-DE) and mass spectrometry (MS) for proteomic analysis of rat aortas.
• Western blot, immunohistochemistry, and serum analysis in CKD patients to validate protein changes.
• Pathway analysis (KOGnitor, Ingenuity Pathway Analysis) to understand functional implications.
• Pharmacological intervention with enalapril in SNX rats.

Main Results:

• SNX rats exhibited aortic stiffness similar to CKD patients.
• Proteomic analysis revealed significant up-regulation and down-regulation of proteins in SNX rat aortas.
• Decreased heat shock protein 27 (HSP27) and increased milk fat globule epidermal growth factor-8 (MFG-E8) were validated.
• MFG-E8 was identified as a key protein associated with aortic stiffness and impaired renal function in CKD patients.
• Enalapril treatment improved aortic stiffness and reduced MFG-E8 deposition in SNX rats.

Conclusions:

• MFG-E8 is a significant biomarker for aortic stiffness in CKD.
• Targeting MFG-E8 and related pathways may offer therapeutic benefits for cardiovascular complications in CKD.
• The study provides a comprehensive proteomic profile of aortic stiffness in CKD, highlighting potential therapeutic targets.